Di Martino Simona, Amico Pietro, De Rosa Maria
Medicinal Chemistry Group, Fondazione Ri.MED, via Filippo Marini 14, 90128, Palermo, Italy.
Top Curr Chem (Cham). 2025 Mar 21;383(2):16. doi: 10.1007/s41061-025-00502-2.
Bridged heterocycles are highly relevant in medicinal chemistry and drug discovery due to the unique features associated with their three-dimensional configuration that ensures great scaffold complexity. In general, inserting bridged systems into a chemical structure positively influences the pharmacokinetic (PK) profile of leads, reducing lipophilicity and enhancing metabolic stability. Several optimization studies show that bridged systems often promoted a significant improvement of the small molecule-enzyme binding interaction due to conformational changes within the biological target active site. To date, many drugs including bridged cores are available in the market to cure several diseases. Given the broad range of biological activities of naturally occurring and (semi)-synthetic bridgehead heterocycles, here, we have thoroughly reviewed the rational design and the structure-activity relationship (SAR) studies of the most remarkable bridged compounds developed during the past decade, to highlight both the chemical and biological roles of these motifs.
桥连杂环在药物化学和药物发现中具有高度相关性,这是因为其三维构型具有独特特征,可确保极大的骨架复杂性。一般来说,将桥连体系引入化学结构会对先导化合物的药代动力学(PK)特性产生积极影响,降低亲脂性并增强代谢稳定性。多项优化研究表明,由于生物靶标活性位点内的构象变化,桥连体系常常能显著改善小分子与酶的结合相互作用。迄今为止,市场上有许多含有桥连核心的药物可用于治疗多种疾病。鉴于天然存在的以及(半)合成桥头杂环具有广泛的生物活性,在此,我们全面综述了过去十年中开发的最引人注目的桥连化合物的合理设计和构效关系(SAR)研究,以突出这些基序的化学和生物学作用。